These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9442164)

  • 1. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry.
    Verdin SM; Economides DL
    Br J Obstet Gynaecol; 1998 Jan; 105(1):63-7. PubMed ID: 9442164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
    ; Prabhu M; Kuller JA; Biggio JR
    Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center.
    Sohl BD; Scioscia AL; Budorick NE; Moore TR
    Am J Obstet Gynecol; 1999 Oct; 181(4):898-903. PubMed ID: 10521750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21.
    Vintzileos AM; Campbell WA; Rodis JF; Guzman ER; Smulian JC; Knuppel RA
    Obstet Gynecol; 1996 Jun; 87(6):948-52. PubMed ID: 8649704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography.
    Vintzileos AM; Egan JF
    Am J Obstet Gynecol; 1995 Mar; 172(3):837-44. PubMed ID: 7892872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
    Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
    Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
    Sullivan A; Giudice T; Vavelidis F; Thiagarajah S
    Am J Obstet Gynecol; 1999 Aug; 181(2):260-5. PubMed ID: 10454666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated fetal pyelectasis and chromosomal abnormalities.
    Coco C; Jeanty P
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):732-8. PubMed ID: 16150267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
    Nyberg DA; Luthy DA; Cheng EY; Sheley RC; Resta RG; Williams MA
    Am J Obstet Gynecol; 1995 Oct; 173(4):1030-5. PubMed ID: 7485289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis.
    Smith-Bindman R; Hosmer W; Feldstein VA; Deeks JJ; Goldberg JD
    JAMA; 2001 Feb; 285(8):1044-55. PubMed ID: 11209176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy.
    Nyberg DA; Souter VL; El-Bastawissi A; Young S; Luthhardt F; Luthy DA
    J Ultrasound Med; 2001 Oct; 20(10):1053-63. PubMed ID: 11587012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Choroid plexus cysts and risk of trisomy 18. Modifications regarding maternal age and markers].
    Hurt K; Sottner O; Záhumenský J; Halaska M; Krcmár M; Driák D; Zmrhalová B; Rakovicová I
    Ceska Gynekol; 2007 Jan; 72(1):49-52. PubMed ID: 17357350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
    Spencer K
    Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.